Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Open accessThe DOI matches its Crossref record; 52 of the 55 references it cites were found in a registry or an index.
Abstract
The autoimmune disease immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) is caused by mutations in the forkhead box protein P3 (FOXP3) gene. In the mouse model of FOXP3 deficiency, the lack of CD4+ CD25+ Tregs is responsible for lethal autoimmunity, indicating that FOXP3 is required for the differentiation of this Treg subset. We show that the number and phenotype of CD4+ CD25+ T cells from IPEX patients are comparable to those of normal donors. CD4+ CD25high T cells from IPEX patients who express FOXP3 protein suppressed the in vitro proliferation of effector T cells from normal donors, when activated by "weak" TCR stimuli. In contrast, the suppressive function of CD4+ CD25high T cells from IPEX patients who do not express FOXP3 protein was profoundly impaired. Importantly, CD4+ CD25high T cells from either FOXP3+ or FOXP3- IPEX patients showed altered suppression toward autologous effector T cells. Interestingly, IL-2 and IFN-gamma production by PBMCs from IPEX patients was significantly decreased. These findings indicate that FOXP3 mutations in IPEX patients result in heterogeneous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+ CD25high Tregs but rather to a dysfunction in these cells and in effector T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Loss of function mutations of Foxp3 lead to the manifestation of the scurfy phenotype in mice, corresponding to the IPEX-syndrome in humans [434].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [434]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Cited by
Genetics, pathogenesis and clinical interventions in type 1 diabetes
Bluestone, J. A., Herold, K., & Eisenbarth, G. (2010) · Nature · doi:10.1038/nature08933 · Cited by 1,265
Interleukin‐10‐secreting type 1 regulatory T cells in rodents and humans
Grazia Roncarolo, M., Gregori, S., Battaglia, M., Bacchetta, R., Fleischhauer, K., & Levings, M. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00420.x · Cited by 1,173
Self-citationType 1 diabetes immunotherapy using polyclonal regulatory T cells
Bluestone, J. A., Buckner, J. H., Fitch, M., Gitelman, S. E., Gupta, S., Hellerstein, M. K., Herold, K. C., Lares, A., Lee, M. R., Li, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4134 · Cited by 1,033
“Mutations or deficiency in the FOXP3 gene in scurfy mice or immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) patients results in a reduced and/or nonfunctional Treg compartment, leading to a fatal multiorgan autoimmune disease (12).”
BackgroundType 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022
“One such example is found in the IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), in which mutations in the Foxp3 transcription factor lead to the dysfunction of regulatory T cells (Tregs) and wasting multiorgan autoimmunity (26, 77, 474).”
BackgroundGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872
“Surprisingly, however, we found that, depending on the type of mutation, IPEX patients can have normal numbers of nTregs that are suppressive under conditions of weak activation ( 6 ).”
BackgroundSelf-citationOhkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, A., Ito, Y., Osaki, M., Tanaka, Y., Yamashita, R., Nakano, N., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.010 · Cited by 754
“Similarly, phenotypically Treg-like cells are found in some IPEX patients with FOXP3 mutation or deletion (Bacchetta et al., 2006).”
BackgroundBattaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
“We have indeed recently shown that in IPEX patients with FOXP3 mutation and T1D, the level of suppression depends not only on the function of Tregs, but also on the T effector cells (35).”
BackgroundHill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D., & Benoist, C. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.010 · Cited by 632
“…of the Treg cell lineage (including transcriptional activity at the Foxp3 locus) can be selected and persist in vivo in its absence (Gavin et al., 2007; Williams and Rudensky, 2007; Lin et al., 2007), consistent with the existence of Treg-like cells in some IPEX patients (Bacchetta et al., 2006).”
BackgroundResultBennett, J. M., Reeves, G., Billman, G. E., & Sturmberg, J. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00316 · Cited by 531
“, genetically-determined defects of normal apoptosis or TREG cell development (80)]; abnormal display of self-antigens (e.”
BackgroundGuidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans
Roncarolo, M.-G., & Battaglia, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2138 · Cited by 515
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
Feuerer, M., Hill, J. A., Mathis, D., & Benoist, C. (2009) · Nature Immunology · doi:10.1038/ni.1760 · Cited by 507
“This observation was also consistent with the existence of T reg -like cells in some patients with IPE”
ResultSun, L., Wang, D., Liang, J., Zhang, H., Feng, X., Wang, H., Hua, B., Liu, B., Ye, S., Hu, X., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27548 · Cited by 475
“The transcription factor FoxP3 acts as a crucial molecule in Treg cell development and function and is widely used as a nuclear marker for Treg cells (34).”
BackgroundCharacterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis
Uhlig, H. H., Coombes, J., Mottet, C., Izcue, A., Thompson, C., Fanger, A., Tannapfel, A., Fontenot, J. D., Ramsdell, F., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5852 · Cited by 463
T cell responses: naïve to memory and everything in between
Pennock, N. D., White, J. T., Cross, E. W., Cheney, E. E., Tamburini, B. A., & Kedl, R. M. (2013) · Advances in Physiology Education · doi:10.1152/advan.00066.2013 · Cited by 461
“In the genetic absence of FOXP3, and thus the absence of regulatory T cells, both people and mice exhibit broad multiorgan autoimmunity (4, 10).”
BackgroundClocchiatti, A., Cora, E., Zhang, Y., & Dotto, G. P. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.30 · Cited by 374
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Lloyd, C. M., & Hawrylowicz, C. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.007 · Cited by 356
Ohkura, N., & Sakaguchi, S. (2020) · Cell Research · doi:10.1038/s41422-020-0324-7 · Cited by 353
From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
Bacchetta, R., Barzaghi, F., & Roncarolo, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13011 · Cited by 338
Self-citationBarzaghi, F., Passerini, L., & Bacchetta, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00211 · Cited by 325
“In support of this hypothesis are the data demonstrating an impaired Th1 cytokine production from IPEX T cells, with relative increase of Th2 cytokines (Chatila et al., 2000; Nieves et al., 2004; Bacchetta et al., 2006).”
BackgroundSelf-citationBarzaghi, F., Amaya Hernandez, L. C., Neven, B., Ricci, S., Kucuk, Z. Y., Bleesing, J. J., Nademi, Z., Slatter, M. A., Ulloa, E. R., Shcherbina, A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.10.041 · Cited by 317
“independence from IVIg substitution (months after HSCT: median; range) 7 (1-48)”
BackgroundInfluentialSelf-citationMechanisms of Inflammatory Responses in Obese Adipose Tissue
Sun, S., Ji, Y., Kersten, S., & Qi, L. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150623 · Cited by 306
Uzel, G., Sampaio, E. P., Lawrence, M. G., Hsu, A. P., Hackett, M., Dorsey, M. J., Noel, R. J., Verbsky, J. W., Freeman, A. F., Janssen, E., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.11.054 · Cited by 301
“In the absence of Treg cells, effector T cells are thought to be free to attack end organs, leading to a distinctive clinical presentation and pathology.(7) A significant number of patients who have symptoms of IPEX syndrome have a wild-type (WT) FOXP3 gene sequence and are”
CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game
Long, S. A., & Buckner, J. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003224 · Cited by 294
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
Grant, C. R., Liberal, R., Mieli-Vergani, G., Vergani, D., & Longhi, M. S. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.012 · Cited by 292
Human inborn errors of immunity: An expanding universe
Notarangelo, L. D., Bacchetta, R., Casanova, J.-L., & Su, H. C. (2020) · Science Immunology · doi:10.1126/sciimmunol.abb1662 · Cited by 276
“Defective Treg function in patients with IPEX [with impaired capacity to suppress proliferation and cytokine production of T effector (Teff) cells] was reported in 2006 (70), establishing Treg dysfunction as the primary pathogenic cause of IPEX.”
BackgroundSelf-citationTorgerson, T. R., & Ochs, H. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.044 · Cited by 272
Torgerson, T. R., Linane, A., Moes, N., Anover, S., Mateo, V., Rieux–Laucat, F., Hermine, O., Vijay, S., Gambineri, E., Cerf–Bensussan, N., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.044 · Cited by 272
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Rosenzwajg, M., Churlaud, G., Mallone, R., Six, A., Dérian, N., Chaara, W., Lorenzon, R., Long, S. A., Buckner, J. H., Afonso, G., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.01.001 · Cited by 257
“Human beings and mice presenting a FOXP3 genetically-determined Treg defect develop multiple organspecific AID [3-8].”
Role of regulatory T cells and FOXP3 in human diseases
Bacchetta, R., Gambineri, E., & Roncarolo, M.-G. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.023 · Cited by 249
Self-citationAguilar-Bryan, L., & Bryan, J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0029 · Cited by 250
Cui, H., Cai, Y., Wang, L., Jia, B., Li, J., Zhao, S., Chu, X., Lin, J., Zhang, X., Bian, Y., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00571 · Cited by 240
“Mature Tregs express high levels of Foxp3 (Fontenot et al., 2003; Bacchetta et al., 2006).”
BackgroundRegulatory T Cells: the Many Faces of Foxp3
Georgiev, P., Charbonnier, L.-M., & Chatila, T. A. (2019) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00684-7 · Cited by 241
Autoimmune polyglandular syndromes
Michels, A. W., & Gottlieb, P. A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.40 · Cited by 232
“IPEX syndrome The rare IPEX syndrome is caused by mutations in the forkhead box P3 ( FOXP3 ) gene, which results in the absence or dysfunction of regulatory T cells”
BackgroundFOXP3 and scurfy: how it all began
Ramsdell, F., & Ziegler, S. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3650 · Cited by 226
Bour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 223
Gambineri, E., Perroni, L., Passerini, L., Bianchi, L., Doglioni, C., Meschi, F., Bonfanti, R., Sznajer, Y., Tommasini, A., Lawitschka, A., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.09.027 · Cited by 224
“We previously reported that the differentiation of CD4(1)CD25(1) Treg cells is not necessarily impaired in patients with IPEX syndrome and that although these cells have different degrees of dysfunction, they can be detected in the patients’ peripheral blood.(26) We now provide evidence that FOXP3 protein expression c…”
BackgroundMethodSelf-citationCD4+ T‐regulatory cells: toward therapy for human diseases
Allan, S. E., Broady, R., Gregori, S., Himmel, M. E., Locke, N., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00634.x · Cited by 223
“For example, the dysfunction in Tregs isolated from IPEX patients with a point mutation in FOXP3 is reversed upon in vitro expansion via an unknown mechanism (198).”
BackgroundSelf-citationHuman IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity
Goudy, K., Aydin, D., Barzaghi, F., Gambineri, E., Vignoli, M., Mannurita, S. C., Doglioni, C., Ponzoni, M., Cicalese, M. P., Assanelli, A., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.004 · Cited by 211
“Indeed, in IPEX lymphoproliferation involves mainly CD4+ T cells and it is mainly due to loss of regulation by intrinsically dysfunctional FOXP3mut Treg rather than being cytokine driven [30,31].”
Self-citationIPEX as a Result of Mutations in FOXP3
van der Vliet, H. J. J., & Nieuwenhuis, E. E. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/89017 · Cited by 199
The role of the CD58 locus in multiple sclerosis
De Jager, P. L., Baecher-Allan, C., Maier, L. M., Arthur, A. T., Ottoboni, L., Barcellos, L., McCauley, J. L., Sawcer, S., Goris, A., Saarela, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813310106 · Cited by 197
“Nonetheless, the importance of FoxP3 in mice and humans is highlighted by the association of mutations in FOXP3 with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome (17) and by the observations that murine null alleles of FOXP3 or even attenuated expression of FoxP3 in murine regula…”
BackgroundChowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
“Mutations in its gene cause functional impairment of Treg cells (12) and might lead to immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome in humans (13).”
Gambineri, E., Ciullini Mannurita, S., Hagin, D., Vignoli, M., Anover-Sombke, S., DeBoer, S., Segundo, G. R. S., Allenspach, E. J., Favre, C., Ochs, H. D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02411 · Cited by 187
The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis
Otsuka, A., Nomura, T., Rerknimitr, P., Seidel, J. A., Honda, T., & Kabashima, K. (2017) · Immunological Reviews · doi:10.1111/imr.12545 · Cited by 185
WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells
Marangoni, F., Trifari, S., Scaramuzza, S., Panaroni, C., Martino, S., Notarangelo, L. D., Baz, Z., Metin, A., Cattaneo, F., Villa, A., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061334 · Cited by 184
“Recent studies reported a compromised function of nTreg cells in several autoimmune diseases, including immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (50), multiple sclerosis (53), autoimmune polyglandular syndrome type II (54), rheumatoid arthritis (52), myasthenia gravis (55), and type 1 d…”
BackgroundThe Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodova, S., Russell, S. E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S. P., MacGregor, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5664 · Cited by 183
Kinnunen, T., Chamberlain, N., Morbach, H., Choi, J., Kim, S., Craft, J., Mayer, L., Cancrini, C., Passerini, L., Bacchetta, R., et al. (2013) · Blood · doi:10.1182/blood-2012-09-457465 · Cited by 177
Self-citationIs FOXP3 a bona fide marker for human regulatory T cells?
Roncarolo, M., & Gregori, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838168 · Cited by 174
Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin
Strauss, L., Czystowska, M., Szajnik, M., Mandapathil, M., & Whiteside, T. L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005994 · Cited by 171
“[7] and/or have reduced suppressive functions [8–10].”
Lawson, J. M., Tremble, J., Dayan, C., Beyan, H., Leslie, R. D. G., Peakman, M., & Tree, T. I. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03810.x · Cited by 168
Luo, A., Leach, S. T., Barres, R., Hesson, L. B., Grimm, M. C., & Simar, D. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00417 · Cited by 165
Manigold, T., & Racanelli, V. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70289-x · Cited by 164
Structure of a Domain-Swapped FOXP3 Dimer on DNA and Its Function in Regulatory T Cells
Bandukwala, H. S., Wu, Y., Feuerer, M., Chen, Y., Barboza, B., Ghosh, S., Stroud, J. C., Benoist, C., Mathis, D., Rao, A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.017 · Cited by 163
“These findings are consistent with those observed in the clinic: an infant harboring the F373A mutation presented with a severe form of IPEX and developed autoimmune insulin-dependent diabetes mellitus (IDDM) within 2 weeks of life, despite the fact that his CD4CD25 T cells showed normal expression of FOXP3 protein as…”
BackgroundResultInfluentialTolerogenic dendritic cells and regulatory T cells: A two-way relationship
Mahnke, K., Johnson, T. S., Ring, S., & Enk, A. H. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.03.002 · Cited by 159
“Firstly, a subset of CD4CD25 naturally occurring Tregs was purified from blood and other lymphatic organs [6—8], verifying their presence in vivo; secondly, deletion of these Tregs by antibody depletion (in animal models) or by mutation (IPEX syndrome in humans) leads to vigorously enhanced autoimmunity [9—12].”
BackgroundGewies, A., Gorka, O., Bergmann, H., Pechloff, K., Petermann, F., Jeltsch, K. M., Rudelius, M., Kriegsmann, M., Weichert, W., Horsch, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.044 · Cited by 154
Passerini, L., Mel, E. R., Sartirana, C., Fousteri, G., Bondanza, A., Naldini, L., Roncarolo, M. G., & Bacchetta, R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007320 · Cited by 151
Self-citationImmunologic endocrine disorders
Michels, A. W., & Eisenbarth, G. S. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.053 · Cited by 176
“Background—The rare IPEX syndrome (immune dysfunction, polyendocrinopathy, enteropathy, X-linked) is caused by mutations in the forkhead box protein 3 (FOXP3) gene resulting in absent or dysfunctional regulatory T cells (63).”
Backgroundα-CTLA-4 mAb-associated Panenteritis: A Histologic and Immunohistochemical Analysis
Oble, D. A., Mino-Kenudson, M., Goldsmith, J., Hodi, F. S., Seliem, R. M., Dranoff, G., Mihm, M., Hasserjian, R., & Lauwers, G. Y. (2008) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31817150e3 · Cited by 151
Disturbed regulatory T cell homeostasis in multiple sclerosis
Venken, K., Hellings, N., Liblau, R., & Stinissen, P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.12.003 · Cited by 171
Rosenzwajg, M., Languille, E., Dêbiec, H., Hygino, J., Dahan, K., Simon, T., Klatzmann, D., & Ronco, P. M. (2017) · Kidney International · doi:10.1016/j.kint.2017.01.012 · Cited by 152
“Patients with a mutation in FOXP3, a transcription factor which programs the development and function of CD4 + CD25 + regulatory T-cells, occasionally develop MN 20,21 .”
Functional reprogramming of regulatory T cells in the absence of Foxp3
Charbonnier, L.-M., Cui, Y., Stephen-Victor, E., Harb, H., Lopez, D., Bleesing, J. J., Garcia-Lloret, M. I., Chen, K., Ozen, A., Carmeliet, P., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0442-x · Cited by 145
d'Hennezel, E. B., Dhuban, K. B., Torgerson, T. R., & Piccirillo, C. A. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100759 · Cited by 160
Lin, S. ‐., Chen, K. ‐., Lin, C., Kuo, C. ‐., Ling, Q., & Chan, C. ‐. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01882.x · Cited by 153
Kang, M., & Martín, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.003 · Cited by 152
“Patients with genetic mutations in FoxP3, that serves as a lineage specification factor of Treg cells, always develop inflammation in the gut through lymphocytic infiltration of the intestinal mucosa [118,119].”
BackgroundTregopathies: Monogenic diseases resulting in regulatory T-cell deficiency
Cepika, A., Sato, Y., Liu, J. M.-H., Uyeda, M. J., Bacchetta, R., & Roncarolo, M. G. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.026 · Cited by 157
“Despite sometimes normal FOXP3 expression level, Treg cells of patients with IPEX syndrome are unable to suppress Teff cells.(67,68) In addition, FOXP3(2) Teff cells display a skewed phenotype toward TH2, TH17, and memory T cells; increased proliferation; and reduced TCR repertoire.”
Self-citationHuman CD4 and CD8 regulatory T cells in infectious diseases and vaccination
Joosten, S. A., & Ottenhoff, T. H. M. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.07.017 · Cited by 139
Taflin, C., Miyara, M., Nochy, D., Valeyre, D., Naccache, J., Altare, F., Peyron, P., Badoual, C., Bruneval, P., Haroche, J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080580 · Cited by 131
“Although the molecular mechanisms of Treg-mediated suppression of immune responses have not been completely elucidated,(10) there is clear evidence that Treg impairment can be a cause of uncontrolled inflammatory processes.(11) We have previously shown a global amplification of CD4 CD25 Tregs in active sarcoidosis.”
BackgroundRegulatory T‐cell therapy for inflammatory bowel disease: more questions than answers
Himmel, M. E., Yao, Y., Orban, P. C., Steiner, T. S., & Levings, M. K. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03572.x · Cited by 128
Thiruppathi, M., Rowin, J., Ganesh, B. B., Sheng, J. R., Prabhakar, B. S., & Meriggioli, M. N. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.09.012 · Cited by 143
“Genetic alterations in the FOXP3 gene as observed in IPEX patients are associated with reduced numbers of FOXP3+ Tregs or impaired Treg function, depending on the type of mutation[43].”
BackgroundMechanism of Action of Glatiramer Acetate in Treatment of Multiple Sclerosis
Weber, M. S., Hohlfeld, R., & Zamvil, S. S. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.08.002 · Cited by 139
“Its genetic defect results in impaired function of Treg, which is associated with in an autoimmune and inflammatory syndrome in humans as well as in mice.(35) Similarly, the experimental deletion of Treg in mice causes various spontaneous organ-specific autoimmune diseases.”
BackgroundLonghi, M. S., Meda, F., Wang, P., Samyn, M., Mieli‐Vergani, G., Vergani, D., & Ma, Y. (2008) · Hepatology · doi:10.1002/hep.22071 · Cited by 124
Imbalance of Th17/Treg in Different Subtypes of Autoimmune Thyroid Diseases
Li, C., Yuan, J., Zhu, Y., Yang, X.-J., Wang, Q. A., Xu, J., He, S., & Zhang, J. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452541 · Cited by 129
Regulatory T cells and breast cancer: implications for immunopathogenesis
Watanabe, M. A. E., Oda, J. M. M., Amarante, M. K., & Voltarelli, J. C. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9247-y · Cited by 138
“Although many authors consider FoxP3 protein the most important Tregs marker [32, 38], it does not necessarily confer a Treg phenotype when expressed in CD4 T lymphocytes [39, 40].”
BackgroundRegulatory T cells as therapeutic targets in rheumatoid arthritis
Esensten, J. H., Wofsy, D., & Bluestone, J. A. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.183 · Cited by 126
TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic?
Marwaha, A. K., Leung, N. J., McMurchy, A. N., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00129 · Cited by 120
Interindividual variation in human T regulatory cells
Ferraro, A., D’Alise, A. M., Raj, T., Asinovski, N., Phillips, R., Ergun, A., Replogle, J. M., Bernier, A., Laffel, L., Stranger, B. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401343111 · Cited by 119
Bhaumik, S., & Basu, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00254 · Cited by 119
“Patients with mutations in FoxP3 that result in non-functional or reduced numbers of Treg cells, suffer from severe intestinal inflammation (127).”
BackgroundClinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes
Rubio-Cabezas, O., Minton, J. A. L., Caswell, R., Shield, J. P., Deiss, D., Sumnik, Z., Cayssials, A., Herr, M., Loew, A., Lewis, V., et al. (2009) · Diabetes Care · doi:10.2337/dc08-1188 · Cited by 119
“Enteropathy was present in virtually all of them, although diabetes was frequently absent (9-11).”
BackgroundThe Role of the PI3K Signaling Pathway in CD4+ T Cell Differentiation and Function
Han, J. M., Patterson, S. J., & Levings, M. K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00245 · Cited by 118
Colitis-associated cancer: the role of T cells in tumor development
Waldner, M. J., & Neurath, M. F. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0161-8 · Cited by 139
“This importance is shown in patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX), which develop a multiorgan autoimmune disease that includes type I diabetes, hypothyroidism, severe allergies, and inflammatory bowel disease [75].”
Braudeau, C., Racapé, M., Giral, M., Louis, S., Moreau, A., Berthelot, L., Heslan, M., Ashton‐Chess, J., Soulillou, J., & Brouard, S. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00537.x · Cited by 116
“Mutations in the FOXP3 gene are associated with autoimmune pathologies in humans [26] and its role in transplantation has now been clearly demonstrated [27].”
BackgroundRegulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis
Pereira, L. M. S., Gomes, S. T. M., Ishak, R., & Vallinoto, A. C. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00605 · Cited by 138
Kelley, T. W., Pohlman, B. L., Elson, P. J., & Hsi, E. D. (2007) · American Journal of Clinical Pathology · doi:10.1309/nb3947k383dj0lq2 · Cited by 116
“0 74 (76) 12 (16) 86% ± 4% 7 (9) 93% ± 3%”
CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells
Goodwin, M., Lee, E., Lakshmanan, U., Shipp, S., Froessl, L., Barzaghi, F., Passerini, L., Narula, M., Sheikali, A., Lee, C. M., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz0571 · Cited by 114
Self-citationRegulatory T cells and their roles in immune dysregulation and allergy
Pellerin, L., Jenks, J. A., Bégin, P., Bacchetta, R., & Nadeau, K. C. (2014) · Immunologic Research · doi:10.1007/s12026-014-8512-5 · Cited by 128
“The study of patients with IPEX syndrome helped recognize in humans that FOXP3 mutations do not impair the thymic development of Treg cells but rather their function [71].”
Self-citationRegulatory T Cells in Allergy and Asthma
Martín‐Orozco, E., Norte‐Muñoz, M., & Martínez-García, J. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00117 · Cited by 122
“These data suggest fundamental and non-overlapping roles for both Tregs (FOXP3+ and IL-10+) in the control of autoimmune and allergic disorders (9, 21).”
BackgroundRegulatory T Cells in Mycobacterium tuberculosis Infection
Cardona, P., & Cardona, P.-J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02139 · Cited by 122
“IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) syndrome is an autoimmune disease caused by mutations in FoxP3 that lead to Treg dysfunction (21).”
BackgroundRegulatory T cells and immunodeficiency in mycosis fungoides and Sézary syndrome
Krejsgaard, T., Ødum, N., Geisler, C., Wasik, M. A., & Woetmann, A. (2011) · Leukemia · doi:10.1038/leu.2011.237 · Cited by 114
Primary Immune Deficiency Disorders Presenting as Autoimmune Diseases: IPEX and APECED
Vasconcelos, D. D. M., Costa-Carvalho, B. T., Torgerson, T. R., & Ochs, H. D. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9176-5 · Cited by 112
“Despite this activation, cells from IPEX patients have defective IL-2, IFN-γ and TNF-α production [7, 18 ].”
BackgroundEisenbarth, G. S. (2010) · Diabetes · doi:10.2337/db09-1855 · Cited by 106
The pathology of malabsorption: current concepts
Owens, S. R., & Greenson, J. K. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02547.x · Cited by 120
Moes, N. D., Rieux‐Laucat, F., Bègue, B., Verdier, J., Neven, B., Patey, N., Torgerson, T., Pïcard, C., Stolzenberg, M., Ruemmele, C., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.006 · Cited by 105
Oda, J. M. M., Hirata, B. K. B., Guembarovski, R. L., & Watanabe, M. A. E. (2013) · Journal of Genetics · doi:10.1007/s12041-013-0213-7 · Cited by 123
“neous biological abnormalities, leading not necessarily to a lack of differentiation of CD4+CD25highTregs but rather to a dysfunction in these cells and in effector T cells (Bacchetta et al. 2006).”
BackgroundTranscriptome profiling of human FoxP3+ regulatory T cells
Bhairavabhotla, R., Kim, Y. C., Glass, D. D., Escobar, T. M., Patel, M. C., Zahr, R., Nguyen, C. K., Kilaru, G., Muljo, S. A., & Shevach, E. M. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.12.004 · Cited by 111
“In humans, mutations in the FOXP3 gene result in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome [2, 3].”
BackgroundKumar, V. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.05.001 · Cited by 121
Mechanisms of human FoxP3+ Treg cell development and function in health and disease
Attias, M., Al-Aubodah, T.-A., & Piccirillo, C. A. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13290 · Cited by 114
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: A systematic review
Park, J. H., Lee, K. H., Jeon, B., Ochs, H. D., Lee, J. S., Gee, H. Y., Seo, S., Geum, D. I., Piccirillo, C. A., Eisenhut, M., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102526 · Cited by 116
Chen, L., Yang, P., Zhou, H., He, H., Ren, X., Chi, W., Wang, L., & Kijlstra, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1793 · Cited by 105
“Convincing evidence has established that certain mutations in the FOXP3 gene in humans leads to the IPEX syndrome (immunodysregulation, polyendocrinopathy, and enteropathy X-linked syndrome).(7) Apart from FOXP3, human glucocorticoid-induced tumor necrosis factor receptor (GITR), intracellular cytotoxic T lymphocyte a…”
Background
Metadata
- Authors
- Bacchetta, R.
- Affiliations
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Corresponding author
- Bacchetta, R.
- ORCID
- Bacchetta, R.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-06-01
- Volume
- 116
- Issue
- 6
- Pages
- 1713-1722
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1472239
- OpenAlex
- W2095671247
- Cited by
- 511
- References
- 55
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 14 · 2023: 12 · 2022: 18 · 2021: 26 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 31 · 2016: 21 · 2015: 20 · 2014: 29 · 2013: 33 · 2012: 36
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- Università degli Studi di Firenze
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI48779, R01AI048779)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- FOXP3 mutations, IPEX syndrome, regulatory T cells, CD4+CD25high T cells, Treg suppressive function, effector T cells, T cell proliferation inhibition, interleukin-2, interferon-gamma, autoimmunity
- MeSH terms
- Animals, Child, Preschool, Disease Models, Animal, Female, Humans, Infant, Interleukin-2, Leukocytes, Mononuclear, Male, Phenotype, Promoter Regions, Genetic, Protein-Losing Enteropathies, Biomarkers, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Cytokines, Polyendocrinopathies, Autoimmune, Jurkat Cells, Mutation, Missense, Genetic Diseases, X-Linked, T-Lymphocytes, Regulatory, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.